General Information of Drug Formulation (ID: F07352)

Formulation Name
Ertugliflozin 5 mg tablet
Company
Merck Sharp & Dohme
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
PF-04971729 DM79VXT Type-2 diabetes 5A11 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Eisenoxyd E00585 56841934 Colorant
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Polyethylene glycol 3350 E00652 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Triacetin E00080 5541 Humectant; Plasticizing agent; Solvent